Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.

Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine JM, Cao ZA, Kamble S, Kopetz S, André T.

J Clin Oncol. 2018 Mar 10;36(8):773-779. doi: 10.1200/JCO.2017.76.9901. Epub 2018 Jan 20.

PMID:
29355075
2.

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T.

Lancet Oncol. 2017 Sep;18(9):1182-1191. doi: 10.1016/S1470-2045(17)30422-9. Epub 2017 Jul 19. Erratum in: Lancet Oncol. 2017 Sep;18(9):e510.

3.

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Kodack DP, Askoxylakis V, Ferraro GB, Sheng Q, Badeaux M, Goel S, Qi X, Shankaraiah R, Cao ZA, Ramjiawan RR, Bezwada D, Patel B, Song Y, Costa C, Naxerova K, Wong CSF, Kloepper J, Das R, Tam A, Tanboon J, Duda DG, Miller CR, Siegel MB, Anders CK, Sanders M, Estrada MV, Schlegel R, Arteaga CL, Brachtel E, Huang A, Fukumura D, Engelman JA, Jain RK.

Sci Transl Med. 2017 May 24;9(391). pii: eaal4682. doi: 10.1126/scitranslmed.aal4682. Erratum in: Sci Transl Med. 2019 Jan 30;11(477):.

4.

The identification and characterization of a STAT5 gene signature in hematologic malignancies.

Sonkin D, Palmer M, Rong X, Horrigan K, Regnier CH, Fanton C, Holash J, Pinzon-Ortiz M, Squires M, Sirulnik A, Radimerski T, Schlegel R, Morrissey M, Cao ZA.

Cancer Biomark. 2015;15(1):79-87. doi: 10.3233/CBM-140434.

PMID:
25524945
5.

CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.

Vora SR, Juric D, Kim N, Mino-Kenudson M, Huynh T, Costa C, Lockerman EL, Pollack SF, Liu M, Li X, Lehar J, Wiesmann M, Wartmann M, Chen Y, Cao ZA, Pinzon-Ortiz M, Kim S, Schlegel R, Huang A, Engelman JA.

Cancer Cell. 2014 Jul 14;26(1):136-49. doi: 10.1016/j.ccr.2014.05.020. Epub 2014 Jul 4.

6.

Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.

Laing N, McDermott B, Wen S, Yang D, Lawson D, Collins M, Reimer C, Hall PA, Andersén H, Snaith M, Wang X, Bedian V, Cao ZA, Blakey D.

Mol Pharmacol. 2013 Jun;83(6):1247-56. doi: 10.1124/mol.112.084079. Epub 2013 Apr 4.

PMID:
23558446
7.

RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growth.

Nyfeler B, Chen Y, Li X, Pinzon-Ortiz M, Wang Z, Reddy A, Pradhan E, Das R, Lehár J, Schlegel R, Finan PM, Cao ZA, Murphy LO, Huang A.

PLoS One. 2012;7(11):e48548. doi: 10.1371/journal.pone.0048548. Epub 2012 Nov 14.

8.

Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.

Xin H, Herrmann A, Reckamp K, Zhang W, Pal S, Hedvat M, Zhang C, Liang W, Scuto A, Weng S, Morosini D, Cao ZA, Zinda M, Figlin R, Huszar D, Jove R, Yu H.

Cancer Res. 2011 Nov 1;71(21):6601-10. doi: 10.1158/0008-5472.CAN-11-1217. Epub 2011 Sep 15.

9.

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models.

Brown JL, Cao ZA, Pinzon-Ortiz M, Kendrew J, Reimer C, Wen S, Zhou JQ, Tabrizi M, Emery S, McDermott B, Pablo L, McCoon P, Bedian V, Blakey DC.

Mol Cancer Ther. 2010 Jan;9(1):145-56. doi: 10.1158/1535-7163.MCT-09-0554. Epub 2010 Jan 6.

10.

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

Hedvat M, Huszar D, Herrmann A, Gozgit JM, Schroeder A, Sheehy A, Buettner R, Proia D, Kowolik CM, Xin H, Armstrong B, Bebernitz G, Weng S, Wang L, Ye M, McEachern K, Chen H, Morosini D, Bell K, Alimzhanov M, Ioannidis S, McCoon P, Cao ZA, Yu H, Jove R, Zinda M.

Cancer Cell. 2009 Dec 8;16(6):487-97. doi: 10.1016/j.ccr.2009.10.015.

11.

Characterization of glycerol dehydratase expressed by fusing its alpha- and beta-subunits.

Wang XD, Zhang XE, Guo YC, Zhang ZP, Cao ZA, Zhou YF.

Biotechnol Lett. 2009 May;31(5):711-7. doi: 10.1007/s10529-009-9911-x. Epub 2009 Jan 19.

PMID:
19152074
12.

Recombinant glutamine synthetase (GS) from C. glutamicum existed as both hexamers & dedocamers and C-terminal His-tag enhanced inclusion bodies formation in E. coli.

Li Y, Yang G, Huang X, Ye B, Liu M, Lin Z, Li C, Cao ZA.

Appl Biochem Biotechnol. 2009 Dec;159(3):614-22. doi: 10.1007/s12010-008-8493-8. Epub 2009 Jan 16.

PMID:
19148777
13.

[Tracheal reconstruction with memory alloy prosthesis coated with collagen].

Lin HP, Cao ZA, Gu XD, Pan WB, Wu XJ, Zhang GL.

Zhongguo Yi Liao Qi Xie Za Zhi. 2007 Mar;31(2):88-90. Chinese.

PMID:
17552167
14.

[Expression and characterization of formate dehydrogenase gene in Klebisella pneumoniae].

Huang ZH, Zhang YP, Liu M, Wang BG, Cao ZA.

Wei Sheng Wu Xue Bao. 2007 Feb;47(1):64-8. Chinese.

PMID:
17436626
15.

[Research progress in tracheal prostheses].

Lin HP, Cao ZA.

Zhongguo Yi Liao Qi Xie Za Zhi. 2006 May;30(3):196-8. Review. Chinese.

PMID:
16929779
16.

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo.

Cao ZA, Bass KE, Balasubramanian S, Liu L, Schultz B, Verner E, Dai Y, Molina RA, Davis JR, Misialek S, Sendzik M, Orr CJ, Leung L, Callan O, Young P, Dalrymple SA, Buggy JJ.

Mol Cancer Ther. 2006 Jul;5(7):1693-701.

17.

CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.

Buggy JJ, Cao ZA, Bass KE, Verner E, Balasubramanian S, Liu L, Schultz BE, Young PR, Dalrymple SA.

Mol Cancer Ther. 2006 May;5(5):1309-17.

18.

Dendritic cells in human thymus and periphery display a proinsulin epitope in a transcription-dependent, capture-independent fashion.

Garcia CA, Prabakar KR, Diez J, Cao ZA, Allende G, Zeller M, Dogra R, Mendez A, Rosenkranz E, Dahl U, Ricordi C, Hanahan D, Pugliese A.

J Immunol. 2005 Aug 15;175(4):2111-22.

19.

[Measurement of intracellular pH in long-chain dicarboxylic acid-producing yeast Candida tropicalis and its growth activity].

Liu SC, Xie LY, Li C, Cao ZA.

Sheng Wu Gong Cheng Xue Bao. 2004 Mar;20(2):279-83. Chinese.

PMID:
15969122
20.

[Effects of carnitine acetyltransferase gene knockout on long chain dicarboxylic acid production and metabolism of Candida tropicalis].

Gao H, Zhang J, Hua YT, Li C, Cao ZA.

Wei Sheng Wu Xue Bao. 2005 Feb;45(1):102-5. Chinese.

PMID:
15847173
21.
22.

[The chemical decomposition of glutamine and its effect on hybridoma cell culture].

Xin Y, Yang Y, Li Q, Kong J, Cao ZA.

Sheng Wu Gong Cheng Xue Bao. 2001 Jul;17(4):478-80. Chinese.

PMID:
11702715
23.

[The measurement of intra-cellular AOX in recombinant Pichia pastoris].

Gu XY, Li Q, Cao ZA.

Sheng Wu Gong Cheng Xue Bao. 2001 Jul;17(4):474-7. Chinese.

PMID:
11702714
24.

[Study on fermentation of long-chain dicarboxylic acid based on enzymology].

Xiao YZ, Jiao P, Hua YT, Cao ZA.

Sheng Wu Gong Cheng Xue Bao. 2001 Mar;17(2):218-20. Chinese.

PMID:
11411236
25.

Identification of an IFN-gamma responsive region in an intron of the invariant chain gene.

Cao ZA, Moore BB, Quezada D, Chang CH, Jones PP.

Eur J Immunol. 2000 Sep;30(9):2604-11.

26.

The invariant chain gene intronic enhancer shows homology to class II promoter elements.

Moore BB, Cao ZA, McRae TL, Woo CH, Conley S, Jones PP.

J Immunol. 1998 Aug 15;161(4):1844-52.

27.

Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains.

Conboy IM, DeKruyff RH, Tate KM, Cao ZA, Moore TA, Umetsu DT, Jones PP.

J Exp Med. 1997 Feb 3;185(3):439-51. Erratum in: J Exp Med 1997 Mar 17;185(6):1149-51.

28.
29.

Capillary electrophoresis of abnormal hemoglobins associated with alpha-thalassemias.

Zhu M, Wehr T, Levi V, Rodriguez R, Shiffer K, Cao ZA.

J Chromatogr A. 1993 Oct 15;652(1):119-29.

PMID:
8281250
30.
31.

Supplemental Content

Support Center